METHYLPHENIDATE AND ATTRIBUTIONS IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

被引:47
|
作者
PELHAM, WE
VANNATTA, K
GNAGY, EM
LICHT, BG
GREENSLADE, KE
GREINER, AR
MURPHY, DA
MILICH, R
VODDEHAMILTON, M
机构
[1] UNIV OREGON,EUGENE,OR 97403
[2] FLORIDA STATE UNIV,TALLAHASSEE,FL 32306
[3] MED COLL WISCONSIN,MILWAUKEE,WI 53226
[4] UNIV KENTUCKY,LEXINGTON,KY 40506
关键词
D O I
10.1037/0022-006X.60.2.282
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
In Experiment 1, 28 attention-deficit hyperactivity disorder (ADHD) boys underwent a double-blind, placebo-controlled medication assessment in a summer day-treatment program. Daily, boys were asked questions to assess their attributions for and evaluations of their behavior. Objective measures showed improved behavior with methylphenidate; however, boys tended to attribute their performance to effort rather than to medication, particularly when medicated. Experiment 2 involved 38 ADHD boys the following summer and replicated the procedures in Experiment 1, with the addition of a no-pill condition and a comparison of attributions for success and failure outcomes. Simply taking a pill (no-pill vs. placebo comparison) did not show significant effects, whereas the results of Experiment 1 were replicated with placebo-methylphenidate comparisons. Across drug conditions a self-enhancing attributional pattern was obtained; the majority of attributions for success were to ability or effort, whereas attributions for failure were to the pill or to counselors.
引用
收藏
页码:282 / 292
页数:11
相关论文
共 50 条
  • [41] Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder
    Pagerols, M.
    Richarte, V.
    Sanchez-Mora, C.
    Garcia-Martinez, I.
    Corrales, M.
    Corominas, M.
    Cormand, B.
    Casas, M.
    Ribases, M.
    Ramos-Quiroga, J. A.
    [J]. PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 98 - 104
  • [42] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [43] Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment
    Kara, Tayfun
    Akaltun, Ismail
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 484 - 484
  • [44] HEMISPHERIC PROCESSING AND METHYLPHENIDATE EFFECTS IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    MALONE, MA
    KERSHNER, JR
    SWANSON, JM
    [J]. JOURNAL OF CHILD NEUROLOGY, 1994, 9 (02) : 181 - 189
  • [45] Methylphenidate transdermal system for the treatment of attention-deficit/hyperactivity disorder
    Rugino, Thomas
    [J]. FUTURE NEUROLOGY, 2007, 2 (06) : 613 - 620
  • [46] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Alekhya Mandali
    Arjun Sethi
    Mara Cercignani
    Neil A. Harrison
    Valerie Voon
    [J]. Translational Psychiatry, 11
  • [47] Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder
    Sugrue, David
    Bogner, Robin
    Ehret, Megan J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (14) : 1163 - 1170
  • [48] Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
    Rafał R. Jaeschke
    Ewelina Sujkowska
    Magdalena Sowa-Kućma
    [J]. Psychopharmacology, 2021, 238 : 2667 - 2691
  • [49] THE EFFECT OF METHYLPHENIDATE ON OCULAR MOVEMENTS IN THE ATTENTION-DEFICIT DISORDER WITH HYPERACTIVITY
    BLONDIS, TA
    SHAPIRO, BK
    CAPUTE, AJ
    ZEE, DS
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1987, 8 (03): : 177 - 177
  • [50] Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
    Mandali, Alekhya
    Sethi, Arjun
    Cercignani, Mara
    Harrison, Neil A.
    Voon, Valerie
    [J]. TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)